第 1 到 6 筆結果，共 6 筆。
| 公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 | |
|---|---|---|---|---|---|---|---|
| 1 | 2023 | Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants | Sun, CP ; Chiu, CW; Wu, PY; Tsung, SI; Lee, IJ; Hu, CW; Hsu, MF; Kuo, TJ; Lan, YH; Chen, LY; Ng, HY; Chung, MJ; Liao, HN; Tseng, SC; Lo, CH; Chen, YJ; Liao, CC ; Chang, CS; Liang, JJ; Draczkowski, P; Puri, S; Chang, YC ; Huang, JS; Chen, CC; Kau, JH; Chen, YH ; Liu, WC ; Wu, HC ; Hsu, STD ; Wang, IH ; Tao, MH | Molecular Therapy 31(11), 3322-3336 | |||
| 2 | 2023 | Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission | Yang, CF; Liao, CC ; Hsu, HW; Liang, JJ; Chang, CS; Ko, HY; Chang, RH; Tang, WC; Chang, MH; Wang, IH ; Lin, YL | Journal of Biomedical Science 30(1), 87 | |||
| 3 | 2022 | A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern | Lee, I-Jung; Lan, Yu-Hua; Wu, Ping-Yi; Wu, Yan-Wei; Chen, Yu-Hung; Tseng, Sheng-Che; Kuo, Tzu-Jiun; Sun, Cheng-Pu ; Jan, Jia-Tsrong ; Ma, Hsiu-Hua; Liao, Chun-Che ; Liang, Jian-Jong; Ko, Hui-Ying; Chang, Chih-Shin; Liu, Wen-Chun ; Ko, Yi-An; Chen, Yen-Hui ; Sie, Zong-Lin; Tsung, Szu-I; Lin, Yi-Ling ; Wang, I-Hsuan ; Tao, Mi-Hua | Emerging microbes & infections 12(1), 2149353 | |||
| 4 | 2022 | A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants | Lee, I-Jung; Sun, Cheng-Pu ; Wu, Ping-Yi; Lan, Yu-Hua; Wang, I-Hsuan ; Liu, Wen-Chun ; Yuan, Joyce, Pei-Yi; Chang, Yu-Wei; Tseng, Sheng-Che; Tsung, Szu-I; Chou, Yu-Chi ; Kumari, Monika; Lin, Yin-Shiou; Chen, Hui-Feng; Chen, Tsung-Yen; Lin, Chih-Chao; Chiu, Chi-Wen; Hsieh, Chung-Hsuan; Chuang, Cheng-Ying; Cheng, Chao-Min; Lin, Hsiu-Ting; Chen, Wan-Yu; Hsu, Fu-Fei; Hong, Ming-Hsiang; Liao, Chun-Che ; Chang, Chih-Shin; Liang, Jian-Jong; Ma, Hsiu-Hua; Chiang, Ming-Tsai; Liao, Hsin-Ni; Ko, Hui-Ying; Chen, Liang-Yu; Ko, Yi-An; Yu, Pei-Yu; Yang, Tzu-Jing; Chiang, Po-Cheng; Hsu, Shang-Te ; Lin, Yi-Ling ; Lee, Chong-Chou; Wu, Han-Chung ; Tao, Mi-Hua | Journal of Biomedical Science 29(1), 49 | |||
| 5 | 2022 | Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants | Lee, IJ; Sun, CP; Wu, PY; Lan, YH; Wang, IH ; Liu, WC ; Tseng, SC; Tsung, SI; Chou, YC ; Kumari, M; Chang, YW; Chen, HF; Lin, YS; Chen, TY; Chiu, CW; Hsieh, CH; Chuang, CY; Lin, CC; Cheng, CM; Lin, HT; Chen, WY; Chiang, PC; Lee, CC; Liao, JC; Wu, HC ; Tao, MH | BioRxiv | |||
| 6 | 2021 | Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19 | Sun, Cheng-Pu ; Jan, Jia-Tsrong ; Wang, I-Hsuan ; Ma, Hsiu-Hua; Ko, Hui-Ying; Wu, Ping-Yi; Kuo, Tzu-Jiun; Liao, Hsin-Ni; Lan, Yu-Hua; Sie, Zong-Lin; Chen, Yen-Hui ; Ko, Yi-An; Liao, Chun-Che ; Chen, Liang-Yu; Lee, I-Jung; Tsung, Szu-I; Lai, Yun-Ju; Chiang, Ming-Tsai; Liang, Jian-Jong; Liu, Wen-Chun ; Wang, Jing-Rong; Yuan, Joyce Pei-Yi; Lin, Yin-Shiou; Tsai, Yi-Ching; Hsieh, Shie-Liang ; Li, Chia-Wei ; Wu, Han-Chung ; Ko, Tai-Ming; Lin, Yi-Ling ; Tao, Mi-Hua | PLoS pathogens 17(8), e1009758 |
